Silver Nitrate Application and Topical Corticosteroids for Hypergranulation Tissue

Randomized Clinical Trial Comparing Silver Nitrate Application With Topical Corticosteroids for Hypergranulation Tissue at Gastrostomy Sites

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02398539

Enrollment

Registered

2015-03-25

Start date

2015-04-30

Completion date

2016-04-30

Last updated

2015-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypergranulation Tissue; Gastrostomy Tube Site

Brief summary

This protocol describes a randomized, two arm clinical trial comparing two topical treatments in patients with hypergranulation tissue at gastrostomy tube sites. The subjects are randomized to either group 1or group 2 treatments: Maximum duration of therapy is 4 weeks. However, the therapy may be discontinued anytime at the discretion of the investigator or if there is resolution of the of the hypergranulation tissue.

Interventions

DRUGSilver Nitrate

Silver Nitrate Sticks

DRUGTriamcinolone

0.5% cream

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

No minimum to 18 Years

Healthy volunteers

Inclusion criteria

1. Pediatric patients \<18 2. Evaluated for hypergranulation at the G-tube site 3. Inpatient and out-patient

Exclusion criteria

Children not meeting the above criteia

Design outcomes

Primary

Measure	Time frame
Maximal reduction in granulation tissue	During maximum of 4 weeks of therapy

Countries

United States

Contacts

Primary ContactEloise Lemon, MSN, MHA, RN

ELEMON@CHMCA.ORG(330) 543-3193

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026